FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearance

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on track to be cleared until Tuesday afternoon, a person familiar with the situation told CNN. The agency is seeking more data on the vaccine, said the source, who declined to be…